Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial

T. Idorn; F. K. Knop; M. B. Jorgensen; T. Jensen; M. Resuli; P. M. Hansen; Karl Bang Christensen; J. J. Holst; M. Hornum; B. Feldt-Rasmussen

doi:10.1007/s00125-014-3355-0

Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial

T. Idorn, F. K. Knop, M. B. Jorgensen, T. Jensen, M. Resuli, P. M. Hansen, Karl Bang Christensen, J. J. Holst, M. Hornum, B. Feldt-Rasmussen

1 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	909
Tidsskrift	Diabetologia
Vol/bind	57
Udgave nummer	1 supplement
Sider (fra-til)	S370-S371
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-014-3355-0
Status	Udgivet - sep. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1007/s00125-014-3355-0

Citationsformater

Idorn, T., Knop, F. K., Jorgensen, M. B., Jensen, T., Resuli, M., Hansen, P. M., Christensen, K. B., Holst, J. J., Hornum, M., & Feldt-Rasmussen, B. (2014). Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial. Diabetologia, 57(1 supplement), S370-S371. [909]. https://doi.org/10.1007/s00125-014-3355-0

Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial. / Idorn, T.; Knop, F. K.; Jorgensen, M. B. et al.

I: Diabetologia, Bind 57, Nr. 1 supplement, 909, 09.2014, s. S370-S371.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Idorn, T, Knop, FK, Jorgensen, MB, Jensen, T, Resuli, M, Hansen, PM, Christensen, KB , Holst, JJ, Hornum, M & Feldt-Rasmussen, B 2014, 'Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial', Diabetologia, bind 57, nr. 1 supplement, 909, s. S370-S371. https://doi.org/10.1007/s00125-014-3355-0

@article{d72cb16f8e1746daa2fd21da4bf04e55,

title = "Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial",

author = "T. Idorn and Knop, {F. K.} and Jorgensen, {M. B.} and T. Jensen and M. Resuli and Hansen, {P. M.} and Christensen, {Karl Bang} and Holst, {J. J.} and M. Hornum and B. Feldt-Rasmussen",

year = "2014",

month = sep,

doi = "10.1007/s00125-014-3355-0",

language = "English",

volume = "57",

pages = "S370--S371",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "1 supplement",

}

TY - ABST

T1 - Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial

AU - Idorn, T.

AU - Knop, F. K.

AU - Jorgensen, M. B.

AU - Jensen, T.

AU - Resuli, M.

AU - Hansen, P. M.

AU - Christensen, Karl Bang

AU - Holst, J. J.

AU - Hornum, M.

AU - Feldt-Rasmussen, B.

PY - 2014/9

Y1 - 2014/9

U2 - 10.1007/s00125-014-3355-0

DO - 10.1007/s00125-014-3355-0

M3 - Conference abstract in journal

C2 - 25134689

SN - 0012-186X

VL - 57

SP - S370-S371

JO - Diabetologia

JF - Diabetologia

IS - 1 supplement

M1 - 909

ER -